Neola Medical AB (publ) (STO:NEOLA)

Market Cap	83.41M
Revenue (ttm)	8.35M
Net Income (ttm)	-10.99M
Shares Out	77.95M
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,999
Average Volume	27,430
Open	1.0400
Previous Close	1.0700
Day's Range	0.9980 - 1.0400
52-Week Range	0.9000 - 3.0400
Beta	1.33
RSI	31.97
Earnings Date	Feb 12, 2026

About Neola Medical AB

Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration. The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022. Neola ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NEOLA

Financial Performance

In 2024, Neola Medical AB's revenue was 10.12 million, an increase of 2.97% compared to the previous year's 9.83 million. Losses were -10.06 million, 11.7% more than in 2023.